ClinicalTrials.gov
public full text
Public Domain
Biomarkers of Iron Homeostasis and Responses to Cystic Fibrosis Pulmonary Exacerbation (CFPE) Treatment
The goal of this study is to identify chemical compounds in the blood and sputum (i.e., biomarkers) that are associated with objective measurements of health status in patients with cystic fibrosis (CF). This study builds upon observations that blood levels of hepcidin-25, a protein that regulates how the body uses and stores iron, vary during CF pulmonary exacerbation (CFPE).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Metabolomic and proteomic signatures of cardiorespiratory fitness for predicting all-cause mortality and non-communicable disease risk: a prospective study in the UK Biobank#356379
- Inflammation, Iron Deficiency and Anaemia Study 1#875564
- Hepcidine and Iron Deficiency in Critically Ill Patients#807570
- Serum Hepcidin in Pregnant Women and the Association With Pregnancy Outcome#866970
- The Optimization of Bioavailability From Iron Supplements: Study 1#1060862
Record · ID 876478
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive